Neuroleptic malignant syndrome: A neuro-psychiatric emergency: Recognition, prevention, and management

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Medicine

Background:

• Neuroleptic Malignant Syndrome (NMS) is a severe complication of antipsychotic medication.
• It is characterized by mental status changes, muscle rigidity, hyperthermia, and autonomic dysfunction.
• NMS is often underestimated rather than overestimated in frequency.

Purpose of the Study:

• To highlight the underestimation of NMS frequency.
• To emphasize the importance of early recognition and prompt management of NMS.
• To discuss the diagnostic challenges and risk factors associated with NMS.

Main Methods:

• Review of clinical observations and existing literature on NMS.
• Analysis of the principal symptoms and diagnostic criteria for NMS.
• Discussion of risk factors and management strategies for NMS.

Main Results:

• NMS is a potentially fatal disorder, often underdiagnosed.
• Key symptoms include mental status changes, rigidity, hyperthermia, and autonomic dysfunction.
• Despite increased awareness, NMS remains a risk with neuroleptic use.

Conclusions:

• Early recognition and prompt management of NMS are vital for reducing mortality.
• Collaboration between medical specialties can improve outcomes for NMS patients.
• Reducing risk factors and prompt intervention are key to managing this dangerous condition.